Dennis M. Grasela

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

Mark Sulkowski, David Gardiner, M. Rodríguez‐Torres et al. · New England Journal of Medicine · 2014 · 1.2K citations

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

Min Gao, Richard E. Nettles, Makonen Belema et al. · Nature · 2010 · 937 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1

Anna S. Lok, David Gardiner, Eric Lawitz et al. · New England Journal of Medicine · 2012 · 609 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Pharmacodynamics of Fluoroquinolones against <i>Streptococcus pneumoniae</i> in Patients with Community-Acquired Respiratory Tract Infections

Paul G. Ambrose, Dennis M. Grasela, Thaddeus H. Grasela et al. · Antimicrobial Agents and Chemotherapy · 2001 · 298 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)*

Richard S. Hotchkiss, Elizabeth Colston, Sachin Yende et al. · Critical Care Medicine · 2019 · 245 citations · Full text

Life Sciences, Immunology, Pharmacology +17